Redmile as of Sept. 30, 2013
Portfolio Holdings for Redmile
Redmile holds 49 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actavis | 5.9 | $39M | 272k | 144.00 | |
| Amgen (AMGN) | 5.8 | $39M | 346k | 111.94 | |
| St. Jude Medical | 5.3 | $35M | 658k | 53.64 | |
| Gilead Sciences (GILD) | 5.0 | $33M | 530k | 62.84 | |
| Cubist Pharmaceuticals | 4.3 | $29M | 453k | 63.55 | |
| Clovis Oncology | 4.3 | $29M | 471k | 60.78 | |
| Regeneron Pharmaceuticals (REGN) | 3.8 | $25M | 80k | 312.87 | |
| Tenet Healthcare Corporation (THC) | 3.7 | $24M | 591k | 41.19 | |
| Catamaran | 3.5 | $23M | 508k | 45.95 | |
| Ariad Pharmaceuticals | 3.5 | $23M | 1.3M | 18.40 | |
| Array BioPharma | 3.4 | $23M | 3.7M | 6.22 | |
| Insulet Corporation (PODD) | 3.3 | $22M | 599k | 36.24 | |
| Brookdale Senior Living (BKD) | 3.0 | $20M | 758k | 26.30 | |
| Puma Biotechnology (PBYI) | 2.8 | $18M | 340k | 53.66 | |
| Hca Holdings (HCA) | 2.7 | $18M | 414k | 42.75 | |
| NuVasive | 2.6 | $17M | 693k | 24.49 | |
| Celgene Corporation | 2.3 | $15M | 99k | 153.92 | |
| Zoetis Inc Cl A (ZTS) | 2.2 | $15M | 466k | 31.12 | |
| Chimerix (CMRX) | 2.2 | $14M | 654k | 21.98 | |
| Cerus Corporation (CERS) | 2.1 | $14M | 2.1M | 6.71 | |
| HeartWare International | 2.0 | $14M | 185k | 73.21 | |
| Merck & Co (MRK) | 2.0 | $14M | 284k | 47.37 | |
| Globus Med Inc cl a (GMED) | 1.9 | $13M | 736k | 17.46 | |
| Capital Senior Living Corporation | 1.9 | $13M | 597k | 21.15 | |
| AstraZeneca (AZN) | 1.9 | $12M | 236k | 51.93 | |
| ArthroCare Corporation | 1.8 | $12M | 343k | 35.58 | |
| Tornier Nv | 1.6 | $11M | 568k | 19.33 | |
| Kythera Biopharmaceuticals I | 1.6 | $10M | 228k | 45.70 | |
| Pacific Biosciences of California (PACB) | 1.3 | $8.7M | 1.6M | 5.53 | |
| Healthways | 1.3 | $8.6M | 463k | 18.51 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $8.3M | 754k | 11.00 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $8.2M | 108k | 75.82 | |
| Accuray Incorporated (ARAY) | 1.2 | $7.9M | 1.1M | 7.39 | |
| VCA Antech | 1.2 | $7.9M | 288k | 27.46 | |
| BioSpecifics Technologies | 1.0 | $6.4M | 327k | 19.47 | |
| Amicus Therapeutics (FOLD) | 0.9 | $5.7M | 2.5M | 2.32 | |
| Sunshine Heart | 0.8 | $5.5M | 471k | 11.58 | |
| Intrexon | 0.7 | $4.8M | 204k | 23.69 | |
| Vocera Communications | 0.7 | $4.6M | 245k | 18.60 | |
| Amarin Corporation | 0.6 | $4.1M | 650k | 6.32 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.5 | $3.5M | 3.0M | 1.15 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $2.9M | 165k | 17.34 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $1.5M | 53k | 27.97 | |
| Receptos | 0.1 | $540k | 21k | 25.96 | |
| Verastem | 0.1 | $386k | 31k | 12.45 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $311k | 6.5k | 47.85 | |
| Allergan | 0.0 | $238k | 2.6k | 90.60 | |
| Repros Therapeutics | 0.0 | $281k | 11k | 26.76 | |
| Perrigo Company | 0.0 | $210k | 1.7k | 123.53 |
